Prediction of pathological complete response after neoadjuvant chemotherapy for HER2-negative breast cancer patients with routine immunohistochemical markers

Abstract Background Pathological complete response (pCR) is an established surrogate marker for prognosis in patients with breast cancer (BC) after neoadjuvant chemotherapy. Individualized pCR prediction based on clinical information available at biopsy, particularly immunohistochemical (IHC) marker...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Lothar Häberle, Ramona Erber, Paul Gass, Alexander Hein, Melitta Niklos, Bernhard Volz, Carolin C. Hack, Rüdiger Schulz-Wendtland, Hanna Huebner, Chloë Goossens, Matthias Christgen, Thilo Dörk, Tjoung-Won Park-Simon, Andreas Schneeweiss, Michael Untch, Valentina Nekljudova, Sibylle Loibl, Arndt Hartmann, Matthias W. Beckmann, Peter A. Fasching
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	BMC 2025-01-01
סדרה:	Breast Cancer Research
נושאים:	pCR Prediction model Breast cancer Neoadjuvant chemotherapy Immunohistochemistry Clinical data
גישה מקוונת:	https://doi.org/10.1186/s13058-025-01960-8
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!